AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11169968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity of polymerase chain reaction signal in younger women
Number of subjects: 1340
Study 9892887 — intervention group
Group type: EXPERIMENTAL
Intervention: Debriefing intervention by midwives (n = 56)
Number of subjects: 120
Study 9892887 — intervention group
Group type: COMPARATOR
Intervention: No debriefing intervention (Control group, n = 58)
Number of subjects: 120
Study 8052479 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil, doxorubicin and mitomycin C (arm A)
Number of subjects: 81
Study 8052479 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil alone (arm B)
Number of subjects: 81
Study 2839000 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-polishing instrument (Prophy Unit, 2000 Satelec)
Number of subjects: 18
Study 2839000 — intervention group
Group type: COMPARATOR
Intervention: Rubber cup with standardized solution of pumice
Number of subjects: 18
Study 31797680 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective internal radiation therapy (SIRT) using 90yttrium resin microspheres
Number of subjects: 85
Study 31797680 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 85
Study 30913244 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal allocation procedures for the Welch‐Satterthwaite tests of standardized and unstandardized contrasts
Number of subjects: 0
Study 30913244 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed allocation strategies combining nonlinear optimization search and iterative screening process
Number of subjects: 0
Study 30913244 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer algorithms developed for power and sample size calculations
Number of subjects: 0
Study 28639369 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with diabetes (n = 922)
Number of subjects: 2033
Study 28639369 — intervention group
Group type: COMPARATOR
Intervention: Patients without diabetes (n = 1111)
Number of subjects: 2033
Study 26550813 — intervention group
Group type: COMPARATOR
Intervention: oral treatment only with gabapentin + celecoxib + amitriptyline
Number of subjects: 128
Study 26550813 — intervention group
Group type: EXPERIMENTAL
Intervention: radiofrequency (RF) pulses using a portable ultrasound device
Number of subjects: 128
Study 23249532 — intervention group
Group type: EXPERIMENTAL
Intervention: High tone electrical muscle stimulation (HTEMS) performed intradialytically for 1 hour.
Number of subjects: 34
Study 23249532 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HTEMS).
Number of subjects: 34
Study 21481147 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean intermittent catheterisation (CIC)
Number of subjects: 87
Study 21481147 — intervention group
Group type: COMPARATOR
Intervention: Transurethral indwelling catheterisation (TIC)
Number of subjects: 87
Study 19500141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydration with isotonic saline + N-acetylcysteine (600 mg p.o. twice daily the preceding day and the day of angiography), n = 73
Number of subjects: 217
Study 19500141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydration with isotonic saline + N-acetylcysteine + theophylline (600 mg N-acetylcysteine p.o. and 200 mg theophylline p.o. twice daily for the preceding day and the day of angiography), n = 72
Number of subjects: 217
Study 19500141 — intervention group
Group type: COMPARATOR
Intervention: Intravenous hydration with isotonic saline, n = 72
Number of subjects: 217
Study 16838577 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced External Counterpulsation (EECP) treatment
Number of subjects: 50
Study 16838577 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 50
Study 14626848 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian method
Number of subjects: 0
Study 14626848 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple logistic regression method
Number of subjects: 0
Study 14626848 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple stepwise regression method
Number of subjects: 0
Study 11491133 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloral hydrate
Number of subjects: 0
Study 11491133 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0
Study 9544646 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional procedures after initial vitrectomy (VIT) or tap-biopsy (TAP)
Number of subjects: 420
Study 7868846 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 1447
Study 7868846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1447
Study 2543143 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acid eicosapentaenoate (EPA)
Number of subjects: 0
Study 2543143 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in marine lipids
Number of subjects: 0
Study 30035670 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (EG) - 90-min training sessions three times/week (n=20)
Number of subjects: 38
Study 30035670 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - maintained daily physical activities (n=18)
Number of subjects: 38
Study 27647856 — intervention group
Group type: EXPERIMENTAL
Intervention: rilonacept
Number of subjects: 42
Study 27647856 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study 26084693 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) supplementation for 15 days
Number of subjects: 14
Study 26084693 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ)
Number of subjects: 14
Study 26084693 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (NDBRJ)
Number of subjects: 14
Study 24083350 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole treatment until esophageal mucosal healing
Number of subjects: 626
Study 24083350 — intervention group
Group type: COMPARATOR
Intervention: Control group (classical healing concept or complete remission concept)
Number of subjects: 626
Study 21349618 — intervention group
Group type: EXPERIMENTAL
Intervention: Early start of dialysis therapy at a glomerular filtration rate of 10‐14 mL/min/1.73 m(2)
Number of subjects: 642
Study 21349618 — intervention group
Group type: COMPARATOR
Intervention: Late start of dialysis therapy at a glomerular filtration rate of 5‐7 mL/min/1.73 m(2)
Number of subjects: 642
Study 21349618 — intervention group
Group type: EXPERIMENTAL
Intervention: Early start of dialysis therapy
Number of subjects: 642
Study 19185645 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib 10 mg once daily for 8 weeks
Number of subjects: 589
Study 19185645 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib 40 mg once daily for 8 weeks
Number of subjects: 589
Study 19185645 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib 150 mg once daily for 8 weeks
Number of subjects: 589
Study 19185645 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib 300 mg once daily for 8 weeks
Number of subjects: 589
Study 19185645 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib coadministered with atorvastatin 20 mg
Number of subjects: 589
Study 19185645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 589
Study 16859781 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 1065
Study 14692989 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily visits to supervise diet, exercise, medication, and self-monitoring blood sugar (Group I)
Number of subjects: 44
Study 14692989 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly visits to supervise diet, exercise, medication education, and self-monitoring blood sugar (Group II)
Number of subjects: 44
Study 14692989 — intervention group
Group type: COMPARATOR
Intervention: Control group (blood examination only)
Number of subjects: 44
Study 14692989 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (Daily visits)
Number of subjects: 44
Study 14692989 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (Weekly visits)
Number of subjects: 44
Study 14692989 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 44
Study 11720834 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone plus ondansetron 8 mg daily (arm B) on days 2-4
Number of subjects: 149
Study 11720834 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 16 mg i.v. alone (arm A)
Number of subjects: 149
Study 9494375 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg/12 hours), Clarithromycin (500 mg/12 hours), Amoxycillin (1 g/12 hours) for 12 days
Number of subjects: 274
Study 9494375 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg/12 hours), Tinidazole (500 mg/12 hours), Clarithromycin (500 mg/12 hours) for 12 days
Number of subjects: 274
Study 9494375 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg/12 hours), Clarithromycin (500 mg/12 hours), Amoxycillin (1 g/6 hours) for 6 days
Number of subjects: 274
Study 9494375 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg/12 hours), Tinidazole (500 mg/12 hours), Clarithromycin (500 mg/12 hours) for 6 days
Number of subjects: 274
Study 8243008 — intervention group
Group type: EXPERIMENTAL
Intervention: Effervescent granules during small bowel meal examination
Number of subjects: 0
Study 3526627 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg atenolol
Number of subjects: 12
Study 3526627 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg propranolol
Number of subjects: 12
Study 3526627 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 27527080 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaborbactam (250 to 2,000 mg)
Number of subjects: 80
Study 27527080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 25201533 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.0 mm optic intraocular lens (Eternity X‐70)
Number of subjects: 31
Study 25201533 — intervention group
Group type: COMPARATOR
Intervention: 6.0 mm optic intraocular lens (Eternity X‐60)
Number of subjects: 31
Study 22737877 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional method tonsillectomy
Number of subjects: 64
Study 22737877 — intervention group
Group type: COMPARATOR
Intervention: Low-temperature plasma radiofrequency tonsillectomy
Number of subjects: 64
Study 20531232 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFSF11 gene polymorphisms (rs2200287, rs9525641, rs1054016)
Number of subjects: 306
Study 20531232 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFSF11 gene polymorphisms (rs346578, rs9525641)
Number of subjects: 306
Study 20531232 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFRSF11A gene polymorphism (rs3826620)
Number of subjects: 306
Study 20531232 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFRSF11A gene polymorphism (rs8086340)
Number of subjects: 306
Study 20531232 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactions of TNFRSF11A and TNFSF11 polymorphisms with environmental factors
Number of subjects: 306
Study 18695463 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa (40,000 U weekly for 4 doses in EPO-2 and 3 doses in EPO-3, starting on ICU day 3)
Number of subjects: 2762
Study 18695463 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 2762
Study 18695463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2762
Study 15955241 — intervention group
Group type: EXPERIMENTAL
Intervention: Idiopathic UIP
Number of subjects: 42
Study 15955241 — intervention group
Group type: COMPARATOR
Intervention: CVD-associated UIP
Number of subjects: 42
Study 15955241 — intervention group
Group type: COMPARATOR
Intervention: Idiopathic NSIP
Number of subjects: 42
Study 12452219 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-aided group (photographs plus verbal instructions)
Number of subjects: 60
Study 12452219 — intervention group
Group type: COMPARATOR
Intervention: Control group (verbal instructions only)
Number of subjects: 60
Study 12452219 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-aided group
Number of subjects: 60
Study 12452219 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 10598520 — intervention group
Group type: EXPERIMENTAL
Intervention: EHF‐puncture
Number of subjects: 222
Study 10598520 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 222
Study 7861487 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nephrostolithotomy alone
Number of subjects: 44
Study 7861487 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nephrostolithotomy combined with extracorporeal shock wave lithotripsy
Number of subjects: 44
Study 7861487 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 44
Study 1508579 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate splinting
Number of subjects: 76
Study 1508579 — intervention group
Group type: COMPARATOR
Intervention: Sonographic surveillance
Number of subjects: 76
Study 6476586 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg morphine sulfate
Number of subjects: 13
Study 6476586 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 13
Study 6476586 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg atropine sulfate
Number of subjects: 13
Study 6476586 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 13
Study 31475623 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron extract (affron®, 14 mg b.i.d.)
Number of subjects: 160
Study 31475623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 30305149 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatectomy-TACE
Number of subjects: 250
Study 30305149 — intervention group
Group type: COMPARATOR
Intervention: Hepatectomy Alone
Number of subjects: 250
Study 26395350 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-free double crown retained dentures with Vectris(©)
Number of subjects: 29
Study 26395350 — intervention group
Group type: COMPARATOR
Intervention: Electroplated gold copings and metal frameworks (Control)
Number of subjects: 29
Study 26395350 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study 25054387 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal (TF) epidural injection of methylprednisolone (80 mg)
Number of subjects: 62
Study 25054387 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasagittal interlaminar (PIL) epidural injection of methylprednisolone (80 mg)
Number of subjects: 62
Study 25054387 — intervention group
Group type: COMPARATOR
Intervention: Both TF and PIL groups
Number of subjects: 62
Study 22036580 — intervention group
Group type: EXPERIMENTAL
Intervention: HVLA manipulation to the lumbosacral joint
Number of subjects: 14
Study 22036580 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 14
Study 21114202 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic Pioglitazone (Utmos) 30 mg/day for 24 weeks
Number of subjects: 85
Study 21114202 — intervention group
Group type: COMPARATOR
Intervention: Original Pioglitazone (Actos) 30 mg/day for 24 weeks
Number of subjects: 85
Study 21114202 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (generic and original Pioglitazone)
Number of subjects: 85
Study 18791976 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-enriched rice with extruded iron premix rice using ferrous sulfate (ExFeSO4)
Number of subjects: 180
Study 18791976 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-enriched rice with extruded iron premix rice using micronized dispersible ferric pyrophosphate (ExFeP80)
Number of subjects: 180
Study 18791976 — intervention group
Group type: COMPARATOR
Intervention: Non-fortified rice (Control)
Number of subjects: 180
Study 15795426 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnitine supplement
Number of subjects: 0
Study 15795426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15795426 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss program (hypoenergetic diet, high in protein, low in carbohydrate, increased physical activity)
Number of subjects: 0
Study 12760312 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg EGCG
Number of subjects: 60
Study 12760312 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg EGCG
Number of subjects: 60
Study 12760312 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg EGCG
Number of subjects: 60
Study 12760312 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg EGCG
Number of subjects: 60
Study 12760312 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg EGCG
Number of subjects: 60
Study 12760312 — intervention group
Group type: EXPERIMENTAL
Intervention: 1600 mg EGCG
Number of subjects: 60
Study 12760312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 10550654 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical fusion (ACF)
Number of subjects: 90
Study 10550654 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy (ACD)
Number of subjects: 90
Study 9514518 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous muscle stimulation using a completely implantable electrical system
Number of subjects: 13
Study 9514518 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous muscle stimulation
Number of subjects: 13
Study 2071201 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional plaster brace applied immediately after reduction of the fracture
Number of subjects: 60
Study 2071201 — intervention group
Group type: COMPARATOR
Intervention: Standard Colles' plaster (control group)
Number of subjects: 60
Study 6400701 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast containing banana
Number of subjects: 8
Study 6400701 — intervention group
Group type: COMPARATOR
Intervention: Breakfast containing orange juice
Number of subjects: 8
Study 6400701 — intervention group
Group type: COMPARATOR
Intervention: Other breakfasts (not specified)
Number of subjects: 8
Study 30903796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide, 7 mg/d
Number of subjects: 1864
Study 30903796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide, 14 mg/d
Number of subjects: 1864
Study 30903796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide, 3 mg/d
Number of subjects: 1864
Study 30903796 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin, 100 mg
Number of subjects: 1864
Study 27768242 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg BID
Number of subjects: 250
Study 27768242 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg QW
Number of subjects: 250
Study 27768242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 27768242 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast (after switching from placebo)
Number of subjects: 250
Study 27768242 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (after switching to apremilast)
Number of subjects: 250
Study 27768242 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast (continuing from apremilast)
Number of subjects: 250
Study 23846523 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubiprostone plus PEG
Number of subjects: 123
Study 23846523 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus PEG
Number of subjects: 123
Study 25372920 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cells
Number of subjects: 30
Study 25372920 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 22325065 — intervention group
Group type: EXPERIMENTAL
Intervention: Beat the Blues (BTB) intervention, involving up to 10 sessions over 4 months with licensed social workers.
Number of subjects: 208
Study 22325065 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (received BTB 4 months later).
Number of subjects: 208
Study 22325065 — intervention group
Group type: EXPERIMENTAL
Intervention: Beat the Blues (BTB) intervention.
Number of subjects: 208
Study 19429875 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 129
Study 19429875 — intervention group
Group type: COMPARATOR
Intervention: Control (Standard Glucose Monitoring)
Number of subjects: 129
Study 18158694 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle stabilizing orthosis
Number of subjects: 11
Study 18158694 — intervention group
Group type: COMPARATOR
Intervention: No ankle stabilizing orthosis (control)
Number of subjects: 11
Study 15230341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor extended release 500‐mg tablet after low‐fat vegetarian diet
Number of subjects: 23
Study 15230341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor extended release 500‐mg tablet after high‐fat non-vegetarian diet
Number of subjects: 23
Study 15230341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor extended release 500‐mg tablet after high‐fat vegetarian diet
Number of subjects: 23
Study 15230341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor extended release 500‐mg tablet after overnight fasting
Number of subjects: 23
Study 15230341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor extended release 500‐mg tablet after rice diet
Number of subjects: 23
Study 11959049 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 28
Study 11959049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 9859117 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at specific points (verum group, n = 22)
Number of subjects: 70
Study 9859117 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at non-specific locations (placebo group, n = 24)
Number of subjects: 70
Study 9859117 — intervention group
Group type: COMPARATOR
Intervention: Only pharmacological treatment (control group, n = 24)
Number of subjects: 70
Study 8706110 — intervention group
Group type: EXPERIMENTAL
Intervention: Familial hemiplegic migraine patients
Number of subjects: 83
Study 8706110 — intervention group
Group type: COMPARATOR
Intervention: Migraine with aura control group
Number of subjects: 83
Study 8706110 — intervention group
Group type: COMPARATOR
Intervention: Migraine without aura control group
Number of subjects: 83
Study 1933356 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (1.5 mg i.m.)
Number of subjects: 0